top of page
Value Proposition
The West-East cross-border pharmaceutical BD transactions have been exploding in recent years.
The vast Asian biotech membership from InScienceWeTrust Community (ISWT-C) provides a large, high-quality deal flow.
“MeritCRO / Mianus Capital / Laurel Hollow Capital / ISWT BioAdvisory" partnership provides “best-in-class” one-stop cross-border BD solution to biotech from the U.S., China, and other territories in the world.
Our founding partner Dr. Leon ‘Jun’ Tang and the other team members have rich experiences in cross-border BD experiences in the Western and China biotechs.
bottom of page